ALPS Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,590
| Closed | -$339K | – | 991 |
|
|
2021
Q3 | $339K | Sell |
7,590
-557
| -7% | -$24.9K | ﹤0.01% | 803 |
|
|
2021
Q2 | $444K | Sell |
8,147
-3,004
| -27% | -$164K | ﹤0.01% | 541 |
|
|
2021
Q1 | $834K | Buy |
11,151
+2,880
| +35% | +$215K | 0.01% | 422 |
|
|
2020
Q4 | $897K | Buy |
8,271
+2,435
| +42% | +$264K | 0.01% | 397 |
|
|
2020
Q3 | $516K | Sell |
5,836
-397
| -6% | -$35.1K | 0.01% | 422 |
|
|
2020
Q2 | $664K | Buy |
+6,233
| New | +$664K | 0.01% | 405 |
|
|
2019
Q2 | – | Sell |
-8,129
| Closed | -$743K | – | 902 |
|
|
2019
Q1 | $743K | Buy |
8,129
+352
| +5% | +$32.2K | 0.01% | 397 |
|
|
2018
Q4 | $433K | Buy |
7,777
+1,822
| +31% | +$101K | ﹤0.01% | 536 |
|
|
2018
Q3 | $709K | Buy |
5,955
+1,228
| +26% | +$146K | ﹤0.01% | 470 |
|
|
2018
Q2 | $483K | Buy |
+4,727
| New | +$483K | ﹤0.01% | 612 |
|